GilchristThomasvariant

The GilchristThomas variant is a single‑nucleotide polymorphism (SNP) located at position 112,345 on chromosome 7 within the GTC1 gene. It was first identified in 2013 by researchers Dr. Eleanor Gilchrist and Dr. Michael Thomas during a genome‑wide association study of early‑onset obesity in a Northern European cohort. The variant involves a cytosine to thymine substitution (C>T) and is designated rs9876543 in dbSNP.

Functional analyses suggest that the T allele alters transcription factor binding sites in the GTC1 promoter region, leading to reduced expression of the adjacent protein‑cysteine transaminase. In vitro studies in hepatic cell lines have shown a 25 % decrease in enzyme activity compared with cells carrying the wild‑type C allele. Epidemiological data indicate that carriers of the T allele exhibit a higher body mass index (BMI) and increased fasting insulin concentrations, although the effect size is modest (odds ratio ≈ 1.12 for obesity).

Diagnostic screening for the GilchristThomas variant employs TaqMan SNP genotyping or next‑generation sequencing panels targeted at the GTC1 locus. While the variant is not currently used as a predictive biomarker in clinical practice, it is a candidate locus for further investigation in metabolic disorder risk models. Additional large‑scale replication studies are ongoing in Asian and African populations to evaluate ethnic differences in allele frequency and phenotypic impact.